Literature DB >> 9491365

Preliminary field evaluation of the combined adulticidal, larvicidal, and wall residual activity of ULV-applied bifenthrin against mosquitoes.

H L Lee1, M S Khadri, Y F Chiang.   

Abstract

The combined adulticidal, larvicidal, and wall residual activity of ULV-applied bifenthrin, a synthetic pyrethroid, was evaluated in houses in Kuala Lumpur, Malaysia, against larvae and adults of lab-bred Aedes aegypti and Culex quinquefasciatus. A portable ULV sprayer was used to disperse a ULV formulation of bifenthrin at a discharge rate of 45 ml/min. The results indicated that bifenthrin sprayed at this rate exhibited all the three activities against the test mosquitoes. Complete adult mortalities were achieved, while very high larvicidal activity was also effected, which persisted for seven days. Wall bioassay with adults of Ae aegypti also resulted in very high mortality, which also persisted for one week. The combined mosquitocidal activities of bifenthrin is considered more effective especially in the control of dengue vectors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9491365

Source DB:  PubMed          Journal:  J Vector Ecol        ISSN: 1081-1710            Impact factor:   1.671


  3 in total

Review 1.  Dengue viral infections.

Authors:  G N Malavige; S Fernando; D J Fernando; S L Seneviratne
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

2.  Contact irritant responses of Aedes aegypti Using sublethal concentration and focal application of pyrethroid chemicals.

Authors:  Hortance Manda; Pankhil Shah; Suppaluck Polsomboon; Theeraphap Chareonviriyaphap; Fanny Castro-Llanos; Amy Morrison; Roxanne G Burrus; John P Grieco; Nicole L Achee
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

Review 3.  New Paradigms for Virus Detection, Surveillance and Control of Zika Virus Vectors in the Settings of Southeast Asia.

Authors:  Indra Vythilingam; Jamal I-C Sam; Yoke F Chan; Loke T Khaw; Wan Y Wan Sulaiman
Journal:  Front Microbiol       Date:  2016-09-13       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.